Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zaaroor

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Acta Neurochirurgica|January 1, 1988
The incidence of multiple meningiomas--do solitary meningiomas exist?B Borovich, Y Doron, J Braun, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 5, 2016
Risk factors associated with death or neurological deterioration among patients with Gram-negative postneurosurgical meningitisA Neuberger, B Shofty, B Bishop, et al.
Neuro-Oncology|October 29, 2010
Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb studyU Bogdahn, P Hau, G Stockhammer, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Acta Neurochirurgica|January 1, 1988
The incidence of multiple meningiomas--do solitary meningiomas exist?B Borovich, Y Doron, J Braun, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 5, 2016
Risk factors associated with death or neurological deterioration among patients with Gram-negative postneurosurgical meningitisA Neuberger, B Shofty, B Bishop, et al.
Neuro-Oncology|October 29, 2010
Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb studyU Bogdahn, P Hau, G Stockhammer, et al.
Pageof 5